{
    "clinical_study": {
        "@rank": "31934", 
        "arm_group": {
            "arm_group_label": "G6PD testing", 
            "description": "Blood samples will be tested for G6PD activity levels"
        }, 
        "biospec_descr": {
            "textblock": "Left-over venous blood will be spun down and buffy coat and extracted DNA will be stored in\n      labeled tubes for later G6PD genotyping and characterization."
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "In this study the investigators propose to evaluate the performance of several G6PD testing\n      platforms."
        }, 
        "brief_title": "Evaluation of Different G6PD Testing Platforms", 
        "completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Glucose-6-Phosphate Dehydrogenase Deficiency", 
        "condition_browse": {
            "mesh_term": "Glucosephosphate Dehydrogenase Deficiency"
        }, 
        "detailed_description": {
            "textblock": "In this study we propose to evaluate the performance of several G6PD testing platforms. We\n      will also determine the concordance between point-of-care G6PD tests and the\n      spectrophotometric gold standard. This study will also access the sensitivity and\n      specificity between the point-of-care G6PD tests. This study will take place in Indonesia,\n      specifically in the SW Sumba region. We will enroll 700 volunteers."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects must be at least five years of age\n\n          -  Patient / parental consent\n\n          -  Patient willing to allow donated sample to be used in future research\n\n        Exclusion Criteria:\n\n          -  Patients with severe malaria or other severe illness\n\n          -  Patients who received a blood transfusion in the last three months\n\n          -  Patients unwilling to allow donated blood to be used in future research"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "5 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "We will enroll up to 700 volunteers from the SW Sumba region in Indonesia. The SW Sumba\n        region is inland, and isolated from other nearby villages. The general population of SW\n        Sumba are substance farmers."
            }
        }, 
        "enrollment": {
            "#text": "700", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 1, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02104518", 
            "org_study_id": "Eijkman-69"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "glucose-6-phosphate dehydrogenase", 
            "point-of-care diagnostic testing"
        ], 
        "lastchanged_date": "April 3, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Jakarta", 
                    "country": "Indonesia"
                }, 
                "name": "Eijkman Institute for Molecular Biology"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Indonesia"
        }, 
        "number_of_groups": "1", 
        "official_title": "Evaluation of a Point-of-care G6PD Diagnostic Test", 
        "overall_contact": {
            "email": "jabrahams@path.org", 
            "last_name": "Jake Abrahams, BA", 
            "phone": "206.302.4743"
        }, 
        "overall_official": [
            {
                "affiliation": "Eijkman Institute for Molecular Biology", 
                "last_name": "Ari Winasti Satyagraha, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "Eijkman Oxford Clinical Research Unit", 
                "last_name": "Kevin Baird, PhD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Indonesia: National Agency of Drug and Food Control", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Percent agreement between the quantitative results of the G6PD tests and the spectrophotometric test.", 
            "measure": "Determine concordance between point-of-care tests and spectrophotometric gold standard", 
            "safety_issue": "No", 
            "time_frame": "Six months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02104518"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "This is to determine the variance of the sensitivity and specificity of different G6PD point-of-care tests compared to the gold standard.", 
                "measure": "Determine sensitivity and specificity of the point-of-care G6PD tests against the spectrophotometric gold standard", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Percent agreement between the qualitative G6PD test and the categorical results of the spectrophotometric gold standard", 
                "measure": "Measure categorical accuracy of point-of-care G6PD test against by the spectrophotometric gold standard", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Compare sensitivity & specificity of qualitative results of the G6PD test and the categorical results of the florescent spot test.", 
                "measure": "Determine concordance between point-of-care G6PD tests and the florescent spot test", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }, 
            {
                "description": "Determine the profile of the SW Sumba area in regards to normal and deficient population spread.", 
                "measure": "Define the G6PD-normal and deficient profiles in the SW Sumba population.", 
                "safety_issue": "No", 
                "time_frame": "Six months"
            }
        ], 
        "source": "PATH", 
        "sponsors": {
            "collaborator": {
                "agency": "Eijkman Institute of Molecular Biology", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "PATH", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2014", 
        "study_design": "Observational Model: Ecologic or Community, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}